RECHERCHE :   Cancers du sein
Filtrage ? Le champ de filtrage permet de trier les études comportant le mot saisie. La recherche du mot se fait uniquement dans le contenu texte affiché à l'écran.
ETUDE PHASE SITE
BMS CA022-001: Phase 1/2a First-In-Human Study of BMS-986218 Monoclonal Antibody Alone and in Combination with Nivolumab in Advanced Solid Tumors
Tumeurs solides avancées
I, II
CHUV
CHUV-DO-0009-CYBERIMMUNOBREAST-2017: CMP-001 in Combination with Pre-Operative Stereotactic Body Radiation Therapy in Patients with Early Stage Triple Negative Breast Cancer: An Open-Label, Window of Opportunity, Randomized Phase 2 Clinical Study
Early Stage Triple Negative Breast Cancer
II
CHUV
HER2CLIMB-02/SGNTUC-016: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer
Cancer du sein HER2-positif localement avancé ou métastatique non résécable
III
CHUV
IMpassion30/WO39391 : A phase III, multicenter, randomized, open-label study comparing atezolizumab (anti-PDL1 antibody) in combination with adjuvant anthracycline/taxane-based chemotherapy versus chemotherapy alone in patients with operable triple-negative breast cancer
Cancer du sein, triple-négatif
III
CHUV
CHUV-DO-0018-NeoTIL-2019: Pilot Study to Assess the Feasibility, Safety and Efficacy of Adoptive Transfer of Autologous Tumor-Infiltrating Lymphocytes Enriched for Tumor Antigen Specificity (NeoTIL) in Advanced Solid Tumors.
Tumeurs solides
I
CHUV
EPIK-B3/CBYL719H12301 : A Phase III, multicenter, randomized, doubleblind, placebo-controlled study to assess the efficacy and safety of alpelisib (BYL719) in combination with nabpaclitaxel in patients with advanced triple negative breast cancer with either phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) mutation or phosphatase and tensin homolog protein (PTEN) loss without PIK3CA mutation
cancer du sein triple négatif avancé
III
CHUV
SAKK 23/16 / IBCSG 57-18 / ABCSG-53: Tailored AXIllary Surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS). A multicenter randomized phase III trial.
High risk node-positive breast cancer
III
CHUV, HUG
SERENITY: Mindfulness-Based Cancer Recovery program for patients living with a gynecological cancer: a pilot randomized controlled study
gynecological cancer
autre
CHUV, HUG
IBCSG55-17 - TOUCH: Phase II open-label, multicenter, randomized trial of neoadjuvant palbociclib in combination with hormonal therapy and HER2 blockade versus paclitaxel in combination with HER2 blockade for elderly patients with hormone receptor positive/HER2 positive early breast cancer
elderly ER/HER2 positive breast cancer
II
HUG